查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1721211

临床试验外包市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Clinical Trials Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10个工作天内

价格

临床试验外包市场-报告范围

TMR 关于全球临床试验外包市场的报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2019 年至 2035 年期间全球临床试验外包市场的收入，以 2025 年为基准年，2035 年为预测年。该报告也提供了2025年至2035年全球临床试验外包市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初步研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了访谈。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解临床试验外包市场。

市场概况
2024 年的市场价值 507亿美元
2035年的市场价值 1019亿美元
复合年增长率 6.4%

该报告深入探讨了全球临床试验外包市场的竞争格局。我们已经确定了在全球临床试验外包市场中运作的关键参与者，并根据各种属性对每个参与者进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告介绍的全球临床试验外包市场参与者的属性。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球临床试验外包市场分析与预测

第五章：关键见解

  • 重要产业活动
  • 影响分析
  • PESTEL分析
  • 主要国家/地区监管情况
  • 波特五力分析
  • 技术进步
  • 融资/投资方案

第六章：全球市场分析与预测：依服务类型

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：依服务类型，2020-2035
    • 实验室服务
    • 生物分析测试服务
    • 分散临床试验服务
    • 病患招募
    • 场地识别
    • 分析测试服务
    • 临床试验供应和物流服务
    • 协议设计
    • 临床试验资料管理服务
    • 医疗器材测试服务
    • 其他的
  • 市场吸引力分析：按服务类型

第七章：全球市场分析与预测：依治疗领域

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：依治疗领域，2020-2035
    • 肿瘤学
    • 传染病
    • 神经病学
    • 代谢紊乱
    • 免疫学
    • 心臟病学
    • 遗传疾病
    • 女性健康
    • 其他的
  • 市场吸引力分析：按治疗领域

第八章：全球市场分析与预测：按应用

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按应用，2020-2035
    • 小分子
    • 单株抗体
    • 疫苗
    • 细胞与基因治疗
    • 其他的
  • 市场吸引力分析：按应用

第九章：全球市场分析与预测：按最终用户

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2035
    • 製药和生物技术公司
    • 医疗器材製造商
  • 市场吸引力分析：按最终用户

第十章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2035
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第 11 章：北美市场分析与预测

第十二章：欧洲市场分析与预测

第十三章：亚太市场分析与预测

第十四章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第 16 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2024年）
  • 公司简介
    • ICON plc
    • IQVIA
    • Thermo Fisher Scientific Inc.
    • SGS Life Sciences
    • Charles River Laboratories
    • Parexel
    • Syneos Health
    • Medpace
    • LabCorp
    • KCR
    • PRA Health Sciences
    • WuXi AppTec
    • Pharmaron
    • Avance Clinical
    • Pharmaron
Product Code: TMRGL86540

Clinical Trials Outsourcing Market - Scope of Report

TMR's report on the global clinical trials outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global clinical trials outsourcing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical trials outsourcing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the clinical trials outsourcing market.

Market Snapshot
Market Value in 2024US$ 50.7 Bn
Market Value in 2035US$ 101.9 Bn
CAGR6.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global clinical trials outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global clinical trials outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global clinical trials outsourcing market.

The report delves into the competitive landscape of the global clinical trials outsourcing market. Key players operating in the global clinical trials outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global clinical trials outsourcing market profiled in this report.

Key Questions Answered in Global clinical trials outsourcing market Report:

  • What is the sales/revenue generated by clinical trials outsourcing across all regions during the forecast period?
  • What are the opportunities in the global clinical trials outsourcing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Clinical Trials Outsourcing Market - Research Objectives and Research Approach

The comprehensive report on the global clinical trials outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global clinical trials outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global clinical trials outsourcing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Clinical Trials Outsourcing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Clinical Trials Outsourcing Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Impact Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Regulatory Scenario by Key Countries/Regions
  • 5.5. PORTER's Five Forces Analysis
  • 5.6. Technological Advancements
  • 5.7. Fund Raise/Investment Scenario

6. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Service Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Service Type, 2020-2035
    • 6.3.1. Laboratory Services
    • 6.3.2. Bioanalytical Testing Services
    • 6.3.3. Decentralized Clinical Trial Services
    • 6.3.4. Patient Recruitment
    • 6.3.5. Site Identification
    • 6.3.6. Analytical Testing Services
    • 6.3.7. Clinical Trial Supply & Logistic Services
    • 6.3.8. Protocol Designing
    • 6.3.9. Clinical Trial Data Management Services
    • 6.3.10. Medical Device Testing Services
    • 6.3.11. Others
  • 6.4. Market Attractiveness Analysis, by Service Type

7. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Therapeutic Area

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 7.3.1. Oncology
    • 7.3.2. Infectious Diseases
    • 7.3.3. Neurology
    • 7.3.4. Metabolic Disorders
    • 7.3.5. Immunology
    • 7.3.6. Cardiology
    • 7.3.7. Genetic Diseases
    • 7.3.8. Women's Health
    • 7.3.9. Others
  • 7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2020-2035
    • 8.3.1. Small Molecules
    • 8.3.2. Monoclonal Antibodies
    • 8.3.3. Vaccine
    • 8.3.4. Cell & Gene Therapy
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Clinical Trials Outsourcing Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2035
    • 9.3.1. Pharmaceutical and Biotech Companies
    • 9.3.2. Medical Device Manufacturers
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Clinical Trials Outsourcing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Service Type, 2020-2035
    • 11.2.1. Laboratory Services
    • 11.2.2. Bioanalytical Testing Services
    • 11.2.3. Decentralized Clinical Trial Services
    • 11.2.4. Patient Recruitment
    • 11.2.5. Site Identification
    • 11.2.6. Analytical Testing Services
    • 11.2.7. Clinical Trial Supply & Logistic Services
    • 11.2.8. Protocol Designing
    • 11.2.9. Clinical Trial Data Management Services
    • 11.2.10. Medical Device Testing Services
    • 11.2.11. Others
  • 11.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 11.3.1. Oncology
    • 11.3.2. Infectious Diseases
    • 11.3.3. Neurology
    • 11.3.4. Metabolic Disorders
    • 11.3.5. Immunology
    • 11.3.6. Cardiology
    • 11.3.7. Genetic Diseases
    • 11.3.8. Women's Health
    • 11.3.9. Others
  • 11.4. Market Value Forecast, by Application, 2020-2035
    • 11.4.1. Small Molecules
    • 11.4.2. Monoclonal Antibodies
    • 11.4.3. Vaccine
    • 11.4.4. Cell & Gene Therapy
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by End-user, 2020-2035
    • 11.5.1. Pharmaceutical and Biotech Companies
    • 11.5.2. Medical Device Manufacturers
  • 11.6. Market Value Forecast, by Country, 2020-2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Service Type
    • 11.7.2. By Therapeutic Area
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Clinical Trials Outsourcing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Service Type, 2020-2035
    • 12.2.1. Laboratory Services
    • 12.2.2. Bioanalytical Testing Services
    • 12.2.3. Decentralized Clinical Trial Services
    • 12.2.4. Patient Recruitment
    • 12.2.5. Site Identification
    • 12.2.6. Analytical Testing Services
    • 12.2.7. Clinical Trial Supply & Logistic Services
    • 12.2.8. Protocol Designing
    • 12.2.9. Clinical Trial Data Management Services
    • 12.2.10. Medical Device Testing Services
    • 12.2.11. Others
  • 12.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 12.3.1. Oncology
    • 12.3.2. Infectious Diseases
    • 12.3.3. Neurology
    • 12.3.4. Metabolic Disorders
    • 12.3.5. Immunology
    • 12.3.6. Cardiology
    • 12.3.7. Genetic Diseases
    • 12.3.8. Women's Health
    • 12.3.9. Others
  • 12.4. Market Value Forecast, by Application, 2020-2035
    • 12.4.1. Small Molecules
    • 12.4.2. Monoclonal Antibodies
    • 12.4.3. Vaccine
    • 12.4.4. Cell & Gene Therapy
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by End-user, 2020-2035
    • 12.5.1. Pharmaceutical and Biotech Companies
    • 12.5.2. Medical Device Manufacturers
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Service Type
    • 12.7.2. By Therapeutic Area
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Clinical Trials Outsourcing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Service Type, 2020-2035
    • 13.2.1. Laboratory Services
    • 13.2.2. Bioanalytical Testing Services
    • 13.2.3. Decentralized Clinical Trial Services
    • 13.2.4. Patient Recruitment
    • 13.2.5. Site Identification
    • 13.2.6. Analytical Testing Services
    • 13.2.7. Clinical Trial Supply & Logistic Services
    • 13.2.8. Protocol Designing
    • 13.2.9. Clinical Trial Data Management Services
    • 13.2.10. Medical Device Testing Services
    • 13.2.11. Others
  • 13.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 13.3.1. Oncology
    • 13.3.2. Infectious Diseases
    • 13.3.3. Neurology
    • 13.3.4. Metabolic Disorders
    • 13.3.5. Immunology
    • 13.3.6. Cardiology
    • 13.3.7. Genetic Diseases
    • 13.3.8. Women's Health
    • 13.3.9. Others
  • 13.4. Market Value Forecast, by Application, 2020-2035
    • 13.4.1. Small Molecules
    • 13.4.2. Monoclonal Antibodies
    • 13.4.3. Vaccine
    • 13.4.4. Cell & Gene Therapy
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by End-user, 2020-2035
    • 13.5.1. Pharmaceutical and Biotech Companies
    • 13.5.2. Medical Device Manufacturers
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Service Type
    • 13.7.2. By Therapeutic Area
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Clinical Trials Outsourcing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Service Type, 2020-2035
    • 14.2.1. Laboratory Services
    • 14.2.2. Bioanalytical Testing Services
    • 14.2.3. Decentralized Clinical Trial Services
    • 14.2.4. Patient Recruitment
    • 14.2.5. Site Identification
    • 14.2.6. Analytical Testing Services
    • 14.2.7. Clinical Trial Supply & Logistic Services
    • 14.2.8. Protocol Designing
    • 14.2.9. Clinical Trial Data Management Services
    • 14.2.10. Medical Device Testing Services
    • 14.2.11. Others
  • 14.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 14.3.1. Oncology
    • 14.3.2. Infectious Diseases
    • 14.3.3. Neurology
    • 14.3.4. Metabolic Disorders
    • 14.3.5. Immunology
    • 14.3.6. Cardiology
    • 14.3.7. Genetic Diseases
    • 14.3.8. Women's Health
    • 14.3.9. Others
  • 14.4. Market Value Forecast, by Application, 2020-2035
    • 14.4.1. Small Molecules
    • 14.4.2. Monoclonal Antibodies
    • 14.4.3. Vaccine
    • 14.4.4. Cell & Gene Therapy
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by End-user, 2020-2035
    • 14.5.1. Pharmaceutical and Biotech Companies
    • 14.5.2. Medical Device Manufacturers
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Service Type
    • 14.7.2. By Therapeutic Area
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Clinical Trials Outsourcing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Service Type, 2020-2035
    • 15.2.1. Laboratory Services
    • 15.2.2. Bioanalytical Testing Services
    • 15.2.3. Decentralized Clinical Trial Services
    • 15.2.4. Patient Recruitment
    • 15.2.5. Site Identification
    • 15.2.6. Analytical Testing Services
    • 15.2.7. Clinical Trial Supply & Logistic Services
    • 15.2.8. Protocol Designing
    • 15.2.9. Clinical Trial Data Management Services
    • 15.2.10. Medical Device Testing Services
    • 15.2.11. Others
  • 15.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 15.3.1. Oncology
    • 15.3.2. Infectious Diseases
    • 15.3.3. Neurology
    • 15.3.4. Metabolic Disorders
    • 15.3.5. Immunology
    • 15.3.6. Cardiology
    • 15.3.7. Genetic Diseases
    • 15.3.8. Women's Health
    • 15.3.9. Others
  • 15.4. Market Value Forecast, by Application, 2020-2035
    • 15.4.1. Small Molecules
    • 15.4.2. Monoclonal Antibodies
    • 15.4.3. Vaccine
    • 15.4.4. Cell & Gene Therapy
    • 15.4.5. Others
  • 15.5. Market Value Forecast, by End-user, 2020-2035
    • 15.5.1. Pharmaceutical and Biotech Companies
    • 15.5.2. Medical Device Manufacturers
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Service Type
    • 15.7.2. By Therapeutic Area
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. ICON plc
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. IQVIA
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Thermo Fisher Scientific Inc.
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. SGS Life Sciences
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Charles River Laboratories
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Parexel
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Syneos Health
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Medpace
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. LabCorp
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. KCR
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. PRA Health Sciences
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. WuXi AppTec
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Pharmaron
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Avance Clinical
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments
    • 16.3.15. Pharmaron
      • 16.3.15.1. Company Overview
      • 16.3.15.2. Financial Overview
      • 16.3.15.3. Product Portfolio
      • 16.3.15.4. Business Strategies
      • 16.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2020-2035
  • Table 02: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 03: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 04: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 05: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Region, 2020-2035
  • Table 06: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 07: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 08: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 09: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 10: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 11: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 12: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 13: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 14: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 15: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 16: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 17: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 18: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 19: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 20: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 21: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 22: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 23: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 24: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 25: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 26: Middle East & Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 27: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 28: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 29: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 30: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035

List of Figures

  • Figure 01: Global Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 02: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 03: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Laboratory Services, 2020-2035
  • Figure 04: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Bioanalytical Testing Services, 2020-2035
  • Figure 05: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Decentralized Clinical Trial Services, 2020-2035
  • Figure 06: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Patient Recruitment, 2020-2035
  • Figure 07: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Site Identification, 2020-2035
  • Figure 08: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Analytical Testing Services, 2020-2035
  • Figure 09: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Clinical Trial Supply & Logistic Services, 2020-2035
  • Figure 10: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Protocol Designing, 2020-2035
  • Figure 11: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Clinical Trial Data Management Services, 2020-2035
  • Figure 12: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Medical Device Testing Services, 2020-2035
  • Figure 13: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 14: Global Clinical Trials Outsourcing Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
  • Figure 15: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2025-2035
  • Figure 16: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Oncology, 2020-2035
  • Figure 17: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Infectious Diseases, 2020-2035
  • Figure 18: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Neurology, 2020-2035
  • Figure 19: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Metabolic Disorders, 2020-2035
  • Figure 20: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Immunology, 2020-2035
  • Figure 21: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Cardiology, 2020-2035
  • Figure 22: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Genetic Diseases, 2020-2035
  • Figure 23: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Women's Health, 2020-2035
  • Figure 24: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 25: Global Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 26: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 27: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Small Molecules, 2020-2035
  • Figure 28: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Monoclonal Antibodies, 2020-2035
  • Figure 29: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Vaccine, 2020-2035
  • Figure 30: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Cell & Gene Therapy, 2020-2035
  • Figure 31: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 32: Global Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 33: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 34: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Pharmaceutical and Biotech Companies, 2020-2035
  • Figure 35: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Medical Device Manufacturers, 2020-2035
  • Figure 36: Global Clinical Trials Outsourcing Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 37: Global Clinical Trials Outsourcing Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 38: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 39: North America Clinical Trials Outsourcing Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 40: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 41: North America Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 42: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 43: North America Clinical Trials Outsourcing Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
  • Figure 44: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2025-2035
  • Figure 45: North America Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 46: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 47: North America Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 48: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 49: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 50: Europe Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 51: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 52: Europe Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 53: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 54: Europe Clinical Trials Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 55: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 56: Europe Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 57: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 58: Europe Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 59: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 60: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 61: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 62: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 63: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 64: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 65: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 66: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 67: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 68: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 69: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 70: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 71: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 72: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 73: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 74: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 75: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 76: Latin America Clinical Trials Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 77: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 78: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 79: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 80: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 81: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 82: Middle East & Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 83: Middle East & Africa Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 84: Middle East & Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 85: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 86: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 87: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
  • Figure 88: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 89: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 90: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 91: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 92: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035